Cargando…
POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States
Autores principales: | Ngami, A, Christie, T, Ménin, G, Guelfucci, F, Bianic, F, Net, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769621/ http://dx.doi.org/10.1016/j.jval.2021.11.1303 |
Ejemplares similares
-
POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season
por: Ngami, A, et al.
Publicado: (2022) -
RWD111 Influenza Vaccine Sales During the COVID-19 Era
por: Ngami, A, et al.
Publicado: (2022) -
EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?
por: Ngami, A, et al.
Publicado: (2022) -
POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital
por: Cazin, L, et al.
Publicado: (2022) -
PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population
por: Costa, M., et al.
Publicado: (2020)